X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
18
PharmaCompass offers a list of Indomethacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Indomethacin manufacturer or Indomethacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Indomethacin manufacturer or Indomethacin supplier.
PharmaCompass also assists you with knowing the Indomethacin API Price utilized in the formulation of products. Indomethacin API Price is not always fixed or binding as the Indomethacin Price is obtained through a variety of data sources. The Indomethacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish], including repackagers and relabelers. The FDA regulates 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] supplier is an individual or a company that provides 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] active pharmaceutical ingredient (API) or 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] finished formulations upon request. The 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers may include 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] API manufacturers, exporters, distributors and traders.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] DMF (Drug Master File) is a document detailing the whole manufacturing process of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] active pharmaceutical ingredient (API) in detail. Different forms of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] DMFs exist exist since differing nations have different regulations, such as 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] DMF submitted to regulatory agencies in the US is known as a USDMF. 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] USDMF includes data on 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] Drug Master File in Japan (1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] JDMF) empowers 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] JDMF during the approval evaluation for pharmaceutical products. At the time of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with JDMF on PharmaCompass.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP of the European Pharmacopoeia monograph is often referred to as a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] Certificate of Suitability (COS). The purpose of a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] to their clients by showing that a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP has been issued for it. The manufacturer submits a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP holder for the record. Additionally, the data presented in the 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] DMF.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with CEP (COS) on PharmaCompass.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] written confirmation (1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] WC) is an official document issued by a regulatory agency to a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] manufacturer, verifying that the manufacturing facility of a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] APIs or 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] finished pharmaceutical products to another nation, regulatory agencies frequently require a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] WC (written confirmation) as part of the regulatory process.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] suppliers with NDC on PharmaCompass.
1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] GMP manufacturer or 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] GMP API supplier for your needs.
A 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CoA (Certificate of Analysis) is a formal document that attests to 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish]'s compliance with 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] specifications and serves as a tool for batch-level quality control.
1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CoA mostly includes findings from lab analyses of a specific batch. For each 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] may be tested according to a variety of international standards, such as European Pharmacopoeia (1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] EP), 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish] USP).
Market Place
